BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 33035624)

  • 1. Inter/intra-tumoral dose response variations assessed using FDG-PET/CT feedback images: Impact on tumor control and treatment dose prescription.
    Yan D; Chen S; Krauss DJ; Deraniyagala R; Chen P; Ye H; Wilson G
    Radiother Oncol; 2021 Jan; 154():235-242. PubMed ID: 33035624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Voxel Dose-Response Matrix and Dose Prescription Function Derived Using
    Yan D; Chen S; Krauss DJ; Chen PY; Chinnaiyan P; Wilson GD
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):207-218. PubMed ID: 30684661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of uncertainties in quantitative
    Chen S; Yan D; Qin A; Maniawski P; Krauss DJ; Wilson GD
    Med Phys; 2020 Nov; 47(11):5681-5692. PubMed ID: 32966627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic Characteristics and Predictive Capability of Tumor Voxel Dose-Response Assessed Using
    Chen S; Qin A; Yan D
    Front Oncol; 2022; 12():876861. PubMed ID: 35875108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
    Schouten CS; Hakim S; Boellaard R; Bloemena E; Doornaert PA; Witte BI; Braakhuis BJ; Brakenhoff RH; Leemans CR; Hoekstra OS; de Bree R
    Head Neck; 2016 Apr; 38(4):529-35. PubMed ID: 25352335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions.
    Das SK; Miften MM; Zhou S; Bell M; Munley MT; Whiddon CS; Craciunescu O; Baydush AH; Wong T; Rosenman JG; Dewhirst MW; Marks LB
    Med Phys; 2004 Jun; 31(6):1452-61. PubMed ID: 15259648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status.
    Moan JM; Amdal CD; Malinen E; Svestad JG; Bogsrud TV; Dale E
    Radiother Oncol; 2019 Nov; 140():54-61. PubMed ID: 31177043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions.
    Mohamed ASR; Cardenas CE; Garden AS; Awan MJ; Rock CD; Westergaard SA; Brandon Gunn G; Belal AM; El-Gowily AG; Lai SY; Rosenthal DI; Fuller CD; Aristophanous M
    Radiother Oncol; 2017 Aug; 124(2):248-255. PubMed ID: 28774596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of
    Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
    Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy.
    Okamoto S; Shiga T; Yasuda K; Watanabe S; Hirata K; Nishijima KI; Magota K; Kasai K; Onimaru R; Tuchiya K; Kuge Y; Shirato H; Tamaki N
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2147-2154. PubMed ID: 27251644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of FDG-PET/CT fused imaging on tumor volume assessment of head-and-neck squamous cell carcinoma: intermethod and interobserver variations.
    Murakami R; Uozumi H; Hirai T; Nishimura R; Katsuragawa S; Shiraishi S; Toya R; Tashiro K; Kawanaka K; Oya N; Tomiguchi S; Yamashita Y
    Acta Radiol; 2008 Jul; 49(6):693-9. PubMed ID: 18568563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance.
    Helsen N; Van den Wyngaert T; Carp L; Stroobants S
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):1063-1071. PubMed ID: 29478080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatio-temporal stability of pre-treatment 18F-Fludeoxyglucose uptake in head and neck squamous cell carcinomas sufficient for dose painting.
    Rasmussen JH; Vogelius IR; Aznar MC; Fischer BM; Christensen CB; Friborg J; Loft A; Kristensen CA; Bentzen SM; Specht L
    Acta Oncol; 2015; 54(9):1416-22. PubMed ID: 26343280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional imaging to monitor vascular and metabolic response in canine head and neck tumors during fractionated radiotherapy.
    Rødal J; Rusten E; Søvik Å; Skogmo HK; Malinen E
    Acta Oncol; 2013 Oct; 52(7):1293-9. PubMed ID: 23879646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
    Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors.
    Differding S; Sterpin E; Janssens G; Hanin FX; Lee JA; Grégoire V
    Acta Oncol; 2016; 55(2):217-25. PubMed ID: 26079436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
    Dejaco D; Uprimny C; Widmann G; Riedl D; Moser P; Arnold C; Steinbichler TB; Kofler B; Schartinger VH; Virgolini I; Riechelmann H
    Cancer Imaging; 2020 Sep; 20(1):69. PubMed ID: 32993805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo spatial correlation between (18)F-BPA and (18)F-FDG uptakes in head and neck cancer.
    Kobayashi K; Kurihara H; Watanabe Y; Murakami N; Inaba K; Nakamura S; Wakita A; Okamoto H; Umezawa R; Takahashi K; Igaki H; Ito Y; Yoshimoto S; Shigematsu N; Itami J
    Appl Radiat Isot; 2016 Sep; 115():138-146. PubMed ID: 27372808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.